← Back to Search

Intervention (Spotlight AQ) for Type 1 Diabetes

N/A

Recruiting

Led By Mark Clements, MD

Research Sponsored by Children's Mercy Hospital Kansas City

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

16-25 years old

On any diabetes treatment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months (approximately)

Awards & highlights

Study Summary

This trial compares a new survey platform called Spotlight AQ to the standard pre-clinic assessment for adolescents and young adults with Type 1 Diabetes. It aims to see if using the Spotlight AQ survey can help

Who is the study for?

This trial is for young people aged 16-25 with Type 1 Diabetes. Participants will use the Spotlight AQ survey before two standard clinic visits and provide feedback on their experience.Check my eligibility

What is being tested?

The study is testing if the Spotlight AQ survey platform can improve A1c levels compared to usual care in young diabetics. It also evaluates user satisfaction from both patients and healthcare providers.See study design

What are the potential side effects?

Since this trial involves a survey tool rather than a medical treatment, there are no direct physical side effects expected from participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 16 and 25 years old.

Select...

I am currently receiving treatment for diabetes.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months (approximately)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months (approximately)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months (approximately) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

HbA1c

Secondary outcome measures

HCP satisfaction with the Spotlight survey

Participant satisfaction

T1D outcomes

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention (Spotlight AQ)Experimental Treatment1 Intervention

Spotlight AQ is an Artificial Intelligence (AI) powered adaptive survey which identifies the main concerns and gaps in patients tailored to their specific needs in preparation for clinic visits

Group II: Standard of CareActive Control1 Intervention

The pre-clinic survey typically given to patients before clinic visits at each institution

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Children's Mercy Hospital Kansas CityLead Sponsor

248 Previous Clinical Trials

935,899 Total Patients Enrolled

Mark Clements, MDPrincipal InvestigatorChildren's Mercy

2 Previous Clinical Trials

450 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current opportunities for potential participants to enroll in this trial?

"According to information available on clinicaltrials.gov, this investigation is presently open for patient enrollment. Originally published on May 6th, 2024, the most recent update was made on April 25th of the same year."

Answered by AI

Are individuals who are 60 years and older eligible for enrollment in this medical study?

"Applicants aged between 16 and 25 meet the eligibility requirements for this study. It is notable that there are a total of 170 trials catering to individuals under 18 years old, and an additional 186 trials available for those above the age of 65."

Answered by AI

Who meets the criteria to be considered as potential participants in this research study?

"To enroll in this study, individuals must possess a diagnosis of type 1 diabetes and fall within the age range of 16 to 25 years. The trial aims to recruit a total of 60 eligible participants."

Answered by AI

What is the current number of individuals actively participating in this clinical investigation?

"Yes, the details on clinicaltrials.gov indicate that this study is currently seeking candidates. The trial was initially posted on May 6th, 2024 and last revised on April 25th, 2024. To complete the study, they aim to enroll a total of 60 patients from one designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)

Mark Clements 2024. "Implementing the Spotlight AQ Platform in Adolescent/ Young Adult (16-25 Years Old) Type 1 Diabetics (T1D)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06390371.

All > Kansas City